Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

4,739 public trials 967 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Completed

A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01812746

Conditions
CRPC, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Investigative Site #16 Los Angeles, California, United States
  • Investigative Site #14 San Francisco, California, United States
  • Investigative Site #17 Fort Meyers, Florida, United States
  • Investigational Site #12 Ann Arbor, Michigan, United States
View Trial Details
Completed

Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen

NCT01046916

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Oregon Health and Sciences University Portland, Oregon, United States
  • University of Wisconsin Hospitals and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

Safety Study of TAK-700 in Subjects With Prostate Cancer.

NCT00569153

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • USC Westside Prostate Cancer Center Beverly Hills, California, United States
  • University of Southern California Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 19 locations
View Trial Details

Related conditions